Representative before the EPO

Employment test 201 - 500 employees
Company dna zacco
operating since 2001
1286.35
Headquarter in Copenhagen and 16 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Representative before the EPO

Employment test 1 - 10 employees
Company dna fleuchaus and gallo partnerschaft
operating since 1967
Headquarter in Munich and 2 offices
active in Legal Services and IP Portfolio Processing

Representative before the EPO

Employment test 1001 - 5000 employees
Company dna jones day
operating since 1893
1247.26
Headquarter in Cleveland and 38 offices
active in Legal Services

Representative before the EPO

Company dna savic patentanwalte
no operation time available
Headquarter in Munich
active in Legal Services

We have observed 17 EP applications Bojan Savic has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after May 26, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12700896

PHENETHYLSULFONE ISOINDOLINE DERIVATIVES AS INHIBITORS OF PDE 4 AND/OR CYTOKINES

IPC classification:
C07D 209/48, C07H 15/26, A61K 31/4035
Applicant:
Celgene Corporation
Agent:
Multiple attorneys, Jones Day
Status:
The patent has been granted
EP11755510

QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF

IPC classification:
A61P 29/00, A61P 35/00, A61P 37/00, C07D 401/14, C07D 403/14, C07D 405/14, C07D 413/14, C07D 417/14, A61K 31/517
Agent:
Multiple attorneys, Jones Day
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12724430

PENTYLENETETRAZOLE DERIVATIVES

IPC classification:
A61P 25/00, C07B 59/00, C07D 487/04, A61K 31/5025
Agent:
Bojan Savic, Jones Day
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11779917

PHARMACEUTICAL FORMULATIONS OF A SUBSTITUTED DIAMINOPURINE

IPC classification:
A61K 9/20, A61K 9/48, A61K 31/505
Applicant:
Signal Pharmaceuticals, LLC
Agent:
Multiple attorneys, Jones Day
Status:
GRANT OF PATENT INTENDED
EP12734039

PROCESSES FOR PREPARING ISOQUINOLINONES AND SOLID FORMS OF ISOQUINOLINONES

IPC classification:
C07D 473/34, A61K 31/497
Applicant:
Intellikine LLC
Agent:
Multiple attorneys, Jones Day
Agent:
Julian Richard John Crump, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC
Agent:
Julian Richard John Crump, Beresford Crump LLP
Status:
PATENT GRANTED
EP13163301

System for performing exercises with selectable weights

IPC classification:
G06F 19/00
Agent:
Bojan Savic, Jones Day
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11755495

THIENOPYRIDINE AND THIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF

IPC classification:
A61P 29/00, A61P 35/00, A61P 37/00, C07D 495/02, A61K 31/4743
Agent:
Multiple attorneys, Jones Day
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11755499

2-CYCLOQUINAZOLINE DERIVATIVES AND METHODS OF USE THEREOF

IPC classification:
A61P 35/00, C07D 403/12, C07D 405/14, A61K 31/517
Agent:
Multiple attorneys, Jones Day
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12796374

PROCESS FOR PREPARING [(3-HYDROXYPYRIDINE-2-CARBONYL)AMINO]ALKANOIC ACIDS, ESTERS AND AMIDES

IPC classification:
C07D 213/79, C07D 213/803, C07D 213/81
Agent:
Bojan Savic, Jones Day
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11755502

ADENOSINE A3 RECEPTOR MODULATING COMPOUNDS AND METHODS OF USE THEREOF

IPC classification:
A61P 27/06, C07D 401/14, C07D 403/12, C07D 405/14, A61K 31/517
Agent:
Multiple attorneys, Jones Day
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11758010

AN OPTICALLY ACTIVE PYRAZOLYLAMINOQUINAZOLINE, AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF

IPC classification:
A61P 35/00, C07D 403/12, A61K 31/517
Agent:
Multiple attorneys, Jones Day
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11758009

AN OPTICALLY ACTIVE PYRAZOLYLAMINOQUINAZOLINE, AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF

IPC classification:
A61P 35/00, C07D 403/12, A61K 31/517
Agent:
Multiple attorneys, Jones Day
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11755500

7-CYCLYLQUINAZOLINE DERIVATIVES AND METHODS OF USE THEREOF

IPC classification:
A61P 35/02, C07D 403/12, C07D 403/14, C07D 405/14, C07D 413/14, A61K 31/517
Agent:
Multiple attorneys, Jones Day
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11755501

4-AZOLYLAMINOQUINAZOLINE DERIVATIVES AND METHODS OF USE THEREOF

IPC classification:
A61P 35/00, C07D 403/12, C07D 417/12, A61K 31/517
Agent:
Multiple attorneys, Jones Day
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11776943

SALTS OF ARYLSULFONAMIDE CCR3 ANTAGONISTS

IPC classification:
A61P 37/00, C07D 211/54, C07D 241/04, A61K 31/495
Agent:
Multiple attorneys, Jones Day
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11755491

HYDROBROMIDE SALTS OF A PYRAZOLYLAMINOQUINAZOLINE

IPC classification:
A61P 35/00, C07D 403/12, A61K 31/517
Agent:
Multiple attorneys, Jones Day
Status:
PATENT GRANTED
EP11777005

CRYSTALINE (8S,9R)-5-FLUORO-8-(4-FLUOROPHENYL)-9-(1-METHYL-1H-1,2,4-TRIAZOL-5-YL)-8,9-DIHYDRO-2H-PYRIDO[4,3,2-DE]PHTALAZIN-3(7H)-ONE TOSYLATE SALT

IPC classification:
A61P 35/00, C07D 471/06, A61K 31/5025
Agent:
Multiple attorneys, Jones Day
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS

Please Sign in to use this feature